Meeting of the National Advisory Council for Healthcare Research and Quality, 41799-41800 [2013-16574]

Download as PDF Federal Register / Vol. 78, No. 133 / Thursday, July 11, 2013 / Notices 41799 EARLY TERMINATIONS GRANTED—Continued [June 1, 2013 thru June 30, 2013] 06/20/2013 20130512 20130889 20130896 06/21/2013 20130930 20130939 20130963 20130965 20130966 20130971 06/24/2013 20130958 20130975 20130978 06/26/2013 20130924 20130948 20130957 ............... ............... ............... G G G Delta Airlines, Inc.; Virgin Group Holdings Limited; Delta Airlines, Inc. Centre Capital Investors V, L.P.; Overhill Farms, Inc.; Centre Capital Investors V, L.P. Blue Acquisition Group, Inc.; Natural Balance Pet Foods, Inc.; Blue Acquisition Group, Inc. ............... ............... ............... ............... ............... ............... G G G G G G Prem Reddy; Catholic Health Initiatives; Prem Reddy. TransDigm Group Incorporated; General Electric Company; TransDigm Group Incorporated. salesforce.com, Inc.; ExactTarget, Inc.; salesforce.com, Inc. Frederic N. Eshelman; Furiex Pharmaceuticals, Inc.; Frederic N. Eshelman. Apax VIII–A L.P.; rue21, inc.; Apax VIII–A L.P. B&G Foods, Inc.; Robert’s American Gourmet Foods, LLC; B&G Foods, Inc. ............... ............... ............... G G G AstraZeneca PLC; Vatera Investment Partners LLC; AstraZeneca PLC. Roark Capital Partners III LP; SKM Equity Fund III, L.P.; Roark Capital Partners III LP. ACP Materials LP; Aurora Equity Partners II L.P.; ACP Materials LP. ............... ............... ............... G G G 20130967 ............... 20130972 ............... G G 20130979 ............... G AstraZeneca PLC; Omthera Pharmaceuticals, Inc.; AstraZeneca PLC. Canadian Imperial Bank of Commerce; Invesco Ltd.; Canadian Imperial Bank of Commerce. Fairfax Financial Holdings Limited; American Safety Insurance Holdings, Ltd.; Fairfax Financial Holdings Limited. Opko Health, Inc.; Prolor Biotech, Inc.; Opko Health, Inc. International Business Machines Corporation; SoftLayer Holdings, Inc.; International Business Machines Corporation. KapStone Paper and Packaging Corporation; Partners Limited; KapStone Paper and Packaging Corporation. 06/27/2013 20130823 20130964 20131011 06/28/2013 20130955 20130984 20130991 ............... ............... ............... G G G Tyman plc; Melrose Industries PLC; Tyman plc. Carl Zeiss Stiftung; Xradia, Inc.; Carl Zeiss Stiftung. Davisville Music Publishing Inc.; Sony Corporation; Davisville Music Publishing Inc. ............... ............... ............... G G G Corvex Master Fund LP; Health Management Associates, Inc.; Corvex Master Fund LP. Mindray Medical International Ltd.; ZONARE Medical Systems, Inc.; Mindray Medical International Ltd. Lundin Mining Corporation; Rio Tinto plc; Lundin Mining Corporation. FOR FURTHER INFORMATION CONTACT: Renee Chapman, Contact Representative or Theresa Kingsberry, Legal Assistant, Federal Trade Commission, Premerger Notification Office, Bureau of Competition, Room H–303, Washington, DC 20580, (202) 326–3100. By Direction of the Commission. Donald S. Clark, Secretary. [FR Doc. 2013–16540 Filed 7–10–13; 8:45 am] BILLING CODE 6750–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES Agency for Healthcare Research and Quality emcdonald on DSK67QTVN1PROD with NOTICES Meeting of the National Advisory Council for Healthcare Research and Quality Agency for Healthcare Research and Quality (AHRQ), HHS. AGENCY: ACTION: Notice of public meeting. In accordance with section 10(a) of the Federal Advisory Committee Act, 5 U.S.C. App. 2, this notice announces a meeting of the National SUMMARY: VerDate Mar<15>2010 18:23 Jul 10, 2013 Jkt 229001 Advisory Council for Healthcare Research and Quality. DATES: The meeting will be held on Friday, July 26, 2013, from 8:30 a.m. to 3:30 p.m. ADDRESSES: The meeting will be held at the Eisenberg Conference Center, Agency for Healthcare Research and Quality, 540 Gaither Road, Rockville, Maryland 20850. FOR FURTHER INFORMATION CONTACT: Jaime Zimmerman, Designated Management Official, at the Agency for Healthcare Research and Quality, 540 Gaither Road, Rockville, Maryland, 20850, (301) 427–1456. For press-related information, please contact Alison Hunt at (301) 427–1244. If sign language interpretation or other reasonable accommodation for a disability is needed, please contact the Food and Drug Administration (FDA) Office of Equal Employment Opportunity and Diversity Management on (301) 827–4840, no later than Friday, July 12, 2013. The agenda, roster, and minutes are available from Ms. Bonnie Campbell, Committee Management Officer, Agency for Healthcare Research and Quality, 540 Gaither Road, Rockville, Maryland, 20850. Ms. Campbell’s phone number is (301) 427– 1554. PO 00000 Frm 00019 Fmt 4703 Sfmt 4703 SUPPLEMENTARY INFORMATION: I. Purpose The National Advisory Council for Healthcare Research and Quality is authorized by Section 941 of the Public Health Service Act, 42 U.S.C. 299c. In accordance with its statutory mandate, the Council is to advise the Secretary of the Department of Health and Human Services and the Director, Agency for Healthcare Research and Quality (AHRQ), on matters related to AHRQ’s conduct of its mission including providing guidance on (A) Priorities for health care research, (B) the field of health care research including training needs and information dissemination on health care quality and (C) the role of the Agency in light of private sector activity and opportunities for public private partnerships. The Council is composed of members of the public, appointed by the Secretary, and Federal ex-officio members specified in the authorizing legislation. II. Agenda On Friday, July 26, 2013, there will be a subcommittee meeting for the National Healthcare Quality and Disparities Report scheduled to begin at 7:30 a.m. E:\FR\FM\11JYN1.SGM 11JYN1 41800 Federal Register / Vol. 78, No. 133 / Thursday, July 11, 2013 / Notices The subcommittee meeting is open the public. The Council meeting will convene at 8:30 a.m., with the call to order by the Council Chair and approval of previous Council summary notes. The meeting is open to the public. The meeting will begin with the AHRQ Director presenting an update on current research, programs, and initiatives. Following the Director’s Update, the agenda includes presentations on AHRQ’s Centers for Education and Research in Therapeutics (CERTS), the National Quality Strategy and Patient and Family Engagement. The final agenda will be available on the AHRQ Web site at www.AHRQ.gov no later than Friday, July 19, 2013. Dated: June 28, 2013. Carolyn M. Clancy, Director. [FR Doc. 2013–16574 Filed 7–10–13; 8:45 am] BILLING CODE 4160–90–M DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention SUPPLEMENTARY INFORMATION: Announcement of Requirements and Registration for ‘‘I VetoViolence Because . . .’’: Teen Dating Violence Prevention Public Service Announcement Contest Authority: 15 U.S.C. 3719 Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). Award Approving Official: Thomas R. Frieden, MD, MPH, Director, Centers for Disease Control and Prevention, and Administrator, Agency for Toxic Substances and Disease Registry. ACTION: Notice. AGENCY: The Centers for Disease Control and Prevention (CDC) located within the Department of Health and Human Services (HHS) launches the ‘‘I VetoViolence Because . . .’’: Teen Dating Violence Prevention Public Service Announcement Contest. The purpose of the contest is to encourage the development of video public service announcements (PSA) that increase the understanding (1) that teen dating violence is a public health problem and (2) that prevention efforts can stop it before it starts. VetoViolence, under HHS/CDC’s National Center for Injury Prevention and Control (Injury Center), asks violence prevention professionals, allied organizations, students, VetoViolence Facebook page fans, and the general public to develop PSAs emcdonald on DSK67QTVN1PROD with NOTICES SUMMARY: VerDate Mar<15>2010 18:23 Jul 10, 2013 Jkt 229001 about teen dating violence and the importance of prevention. The intended effect of the PSAs is to inspire viewers to take steps to stop teen dating violence before it starts by promoting healthy relationships among friends and loved ones and within schools and communities. The PSA finalists and winners will be showcased in three categories on the VetoViolence Facebook page, allowing participants to reach more people with effective and creative messages about preventing teen dating violence. DATES: Contest begins on July 15, 2013 and ends on August 15, 2013. Judging will take place August 16–30, 2013, and winners will be notified on September 6, 2013, with prizes being awarded before September 30, 2013. FOR FURTHER INFORMATION CONTACT: Alan Williams, Media Specialist, Division of Violence Prevention, National Center for Injury Prevention and Control, Centers for Disease Control and Prevention, 4770 Buford Highway NE., MS F64, Atlanta, GA 30341, Telephone: (770) 488–3893, email: wzj4@cdc.gov. Subject of Challenge Competition Contestants entering the ‘‘I VetoViolence Because . . .’’: Teen Dating Violence Prevention Public Service Announcement Contest will be asked to submit short (60 seconds or less), self-made PSAs about teen dating violence and the importance of prevention efforts. Eligibility Rules for Participating in the Competition The challenge is open to any contestant—defined as an individual or team of U.S. citizens or permanent residents of the United States. Contestants may submit more than one video to the challenge. Contestants will be asked to selfidentify as a student, violence prevention professional, or member of the general public when selecting an entry category (Student View, Violence Prevention Professional View, or General Public View). A student is defined as anyone enrolled in middle school, high school, or college and under age 25. Contestants must be at least 13 years of age to enter. To be eligible to win a prize under this challenge, an individual or entity— (1) Shall have registered to participate in the competition under the rules published by the Centers for Disease Control and Prevention’s National Center for Injury Prevention and Control at vetoviolence.challenge.gov; PO 00000 Frm 00020 Fmt 4703 Sfmt 4703 (2) Shall have complied with all the requirements under this section; (3) In the case of a private entity, shall be incorporated in and maintain a primary place of business in the United States, and in the case of an individual, whether participating singly or in a group, shall be a citizen or permanent resident of the United States; and (4) May not be a Federal entity or Federal employee acting within the scope of their employment; (5) Shall not be an HHS employee working on their applications or submissions during assigned duty hours; (6) May not be employees of the HHS/ CDC Injury Center, judges of the challenge, or any other party involved with the design, production, execution, or distribution of the challenge or their immediate family (spouse, parents or step-parents, siblings and step-siblings, and children and step-children). (7) Federal grantees may not use Federal funds to develop COMPETES Act (www.nsf.gov/statistics/about/ BILLS-111hr5116enr.pdf) challenge applications unless consistent with the purpose of their grant award. (8) Federal contractors may not use Federal funds from a contract to develop COMPETES Act challenge applications or to fund efforts in support of a COMPETES Act challenge submission. An individual or entity shall not be deemed ineligible because the individual or entity used Federal facilities or consulted with Federal employees during a competition if the facilities and employees are made available to all individuals and entities participating in the competition on an equitable basis. By participating in this challenge, contestants agree to assume any and all risks and waive claims against the Federal Government and its related entities, except in the case of willful misconduct, for any injury, death, damage, or loss of property, revenue, or profits, whether direct, indirect, or consequential, arising from participation in this prize contest, whether the injury, death, damage, or loss arises through negligence or otherwise. By participating in this challenge, contestants agree to indemnify the Federal Government against third party claims for damages arising from or related to challenge activities. Registration Process for Participants: Contestants must register for the ‘‘I VetoViolence Because . . .’’: Teen Dating Violence Prevention Public Service Announcement Contest Challenge through www.challenge.gov. Interested persons should read the E:\FR\FM\11JYN1.SGM 11JYN1

Agencies

[Federal Register Volume 78, Number 133 (Thursday, July 11, 2013)]
[Notices]
[Pages 41799-41800]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-16574]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Agency for Healthcare Research and Quality


Meeting of the National Advisory Council for Healthcare Research 
and Quality

AGENCY: Agency for Healthcare Research and Quality (AHRQ), HHS.

ACTION: Notice of public meeting.

-----------------------------------------------------------------------

SUMMARY: In accordance with section 10(a) of the Federal Advisory 
Committee Act, 5 U.S.C. App. 2, this notice announces a meeting of the 
National Advisory Council for Healthcare Research and Quality.

DATES: The meeting will be held on Friday, July 26, 2013, from 8:30 
a.m. to 3:30 p.m.

ADDRESSES: The meeting will be held at the Eisenberg Conference Center, 
Agency for Healthcare Research and Quality, 540 Gaither Road, 
Rockville, Maryland 20850.

FOR FURTHER INFORMATION CONTACT: Jaime Zimmerman, Designated Management 
Official, at the Agency for Healthcare Research and Quality, 540 
Gaither Road, Rockville, Maryland, 20850, (301) 427-1456. For press-
related information, please contact Alison Hunt at (301) 427-1244.
    If sign language interpretation or other reasonable accommodation 
for a disability is needed, please contact the Food and Drug 
Administration (FDA) Office of Equal Employment Opportunity and 
Diversity Management on (301) 827-4840, no later than Friday, July 12, 
2013. The agenda, roster, and minutes are available from Ms. Bonnie 
Campbell, Committee Management Officer, Agency for Healthcare Research 
and Quality, 540 Gaither Road, Rockville, Maryland, 20850. Ms. 
Campbell's phone number is (301) 427-1554.

SUPPLEMENTARY INFORMATION: 

I. Purpose

    The National Advisory Council for Healthcare Research and Quality 
is authorized by Section 941 of the Public Health Service Act, 42 
U.S.C. 299c. In accordance with its statutory mandate, the Council is 
to advise the Secretary of the Department of Health and Human Services 
and the Director, Agency for Healthcare Research and Quality (AHRQ), on 
matters related to AHRQ's conduct of its mission including providing 
guidance on (A) Priorities for health care research, (B) the field of 
health care research including training needs and information 
dissemination on health care quality and (C) the role of the Agency in 
light of private sector activity and opportunities for public private 
partnerships.
    The Council is composed of members of the public, appointed by the 
Secretary, and Federal ex-officio members specified in the authorizing 
legislation.

II. Agenda

    On Friday, July 26, 2013, there will be a subcommittee meeting for 
the National Healthcare Quality and Disparities Report scheduled to 
begin at 7:30 a.m.

[[Page 41800]]

The subcommittee meeting is open the public. The Council meeting will 
convene at 8:30 a.m., with the call to order by the Council Chair and 
approval of previous Council summary notes. The meeting is open to the 
public. The meeting will begin with the AHRQ Director presenting an 
update on current research, programs, and initiatives. Following the 
Director's Update, the agenda includes presentations on AHRQ's Centers 
for Education and Research in Therapeutics (CERTS), the National 
Quality Strategy and Patient and Family Engagement. The final agenda 
will be available on the AHRQ Web site at www.AHRQ.gov no later than 
Friday, July 19, 2013.

    Dated: June 28, 2013.
Carolyn M. Clancy,
Director.
[FR Doc. 2013-16574 Filed 7-10-13; 8:45 am]
BILLING CODE 4160-90-M

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.